Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Basel: Roche has announced the introduction of its Chest Pain Triage algorithm as part of the navify Algorithm ...

This weekend marks the 39th anniversary of the Chernobyl nuclear disaster, but we have never been closer to a repeat of the ...

The Swiss president says Switzerland is among 15 countries with which the United States plans to conduct "privileged" ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

Dermatologists recommend no less than SPF 30 for days when you're out in the sun—but they themselves wear SPF 50 or higher ...

Sunscreen use is crucial for protecting children from harmful UV radiation, but experts stress the importance of also using ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

The Patriots got the player they hope to be their LT of the future in Round 1 of the 2025 NFL Draft, but they've got work to ...